CFTR and cystic fibrosis: Currently, three clinical trials are testing the efficiency of mRNA-based therapies targeting different proteins, including the cystic fibrosis transmembrane conductance regulator (CFTR) via lipid nanoparticle inhalation for the treatment of cystic fibrosis (CF) [3].